|
|
|
|
Chronic Lymphocytic Leukemia
Early hope seen for green tea in fighting leukemia 21 Dec 2005
Reuters The patients all had chronic lymphocytic leukemia, or CLL, a form of leukemia that usually arises during or after middle-age and typically progresses slowly. ...
Roswell Park Research Presented at National Hematology Meeting 21 Dec 2005
Newswise (press release) ...of Medicine, is the principal investigator of the first study to report clinical activity of lenalidomide in patients with chronic lymphocytic leukemia (CLL). ...
Chronic leukemia patients may benefit by green tea extracts Dec 14, 2005
Newindpress, WASHINGTON: A component of green tea may lead to clinical improvement in patients with Chronic Lymphocytic Leukemia (CLL), according to a new study published ...
REVLIMID Clinical Results as Oral Treatment Regimen in Chronic ... Dec 12, 2005
PharmaLive.com (press release), 12 /PRNewswire-FirstCall/ -- Celgene Corporation announced that clinical data from a REVLIMID study in Chronic Lymphocytic Leukemia (CLL) were reported at an ...
Mayo Clinic Reports Some Chronic Leukemia Patients May Improve By ... Dec 14, 2005
Science Daily (press release) ...provides preliminary evidence to suggest a component of green tea may lead to clinical improvement in patients with chronic lymphocytic leukemia (CLL). ...
Chronic leukemia patients may benefit by green tea extracts Dec 14, 2005
Webindia123, A component of green tea may lead to clinical improvement in patients with chronic lymphocytic leukemia (CLL), according to a new study published in Leukemia ...
Pharmacyclics' Stock Crushed After Failed Phase III Of Xcytrin Dec 19, 2005
BioWorld Online (subscription), ...non-Hodgkin's lymphoma; Phase II results demonstrated single-agent activity in refractory low-grade lymphoma and chronic lymphocytic leukemia; and preclinical ...
REVLIMID(R) Clinical Results as Oral Treatment Regimen in Chronic ... Dec 12, 2005
Yahoo! News (press release) FirstCall/ -- Celgene Corporation (Nasdaq: CELG - News) announced that clinical data from a REVLIMID study in Chronic Lymphocytic Leukemia (CLL) were reported ...
Seattle Genetics Expands SGN-40 Clinical Program into Chronic ... Nov 29, 2005
Business Wire (press release), ...(Nasdaq:SGEN) announced today that it has initiated a phase I/II clinical trial of SGN-40 in patients with chronic lymphocytic leukemia (CLL). ...
Green tea helps leukemia -- study Dec 14, 2005
United Press International ROCHESTER, Minn., Dec. 14 (UPI) -- A component of green tea is showing benefits in patients with chronic lymphocytic leukemia (CLL), says a new study. ...
REVLIMID(R) Clinical Results as Oral Treatment Regimen in Chronic ... Dec 12, 2005
PR Newswire (press release), 12 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) announced that clinical data from a REVLIMID study in Chronic Lymphocytic Leukemia (CLL) were ...
BioCryst Announces $30.0 Million Common Stock Offering to ... Dec 15, 2005
PR Newswire (press release), ...being studied in a Phase I trial with an oral formulation in cutaneous T-cell lymphoma (CTCL) and a Phase II trial in chronic lymphocytic leukemia (CLL). ...
Studies of Nipent(R) in Combination Cancer Therapies for Treatment ... Dec 9, 2005
PR Newswire (press release), ...the investigational use of Nipent in combination with other chemotherapeutic agents, to treat chemotherapy-naove B-cell Chronic Lymphocytic Leukemia and steroid ...
Annual Meeting of the American Society of Hematology Highlights ... Dec 6, 2005
PR Newswire (press release), Bcl-2 Antisense Oligonucleotide), Fludarabine and Rituximab in Previously Treated and Untreated Subjects with Chronic Lymphocytic Leukemia." Authors: Blanche ...
New Study Reinforces Increased Life Expectancy with MabCampath(R) ... Dec 13, 2005
PR Newswire UK (press release), ...a study presented at the 47th Annual Meeting of the American Society of Hematology in Atlanta, Georgia, patients with B-cell Chronic Lymphocytic Leukemia (B-CLL ...
BioCryst Announces Presentation of Fodosine(TM) Data During the ... Dec 12, 2005
Yahoo! News (press release) ...study, "Development of Forodesine Hydrochloride (FH), an Inhibitor of Purine Nucleoside Phosphorylase, for Patients with Chronic Lymphocytic Leukemia (CLL)" by ...
Studies of Nipent in Combination Cancer Therapies for Treatment of ... Dec 9, 2005
PharmaLive.com (press release), ...investigational use of Nipent in combination with other chemotherapeutic agents, to treat chemotherapy-naïve B-cell Chronic Lymphocytic Leukemia and steroid ...
Point Therapeutics Announces Positive Interim Results at American ... Dec 12, 2005
Business Wire (press release), ...their ongoing Phase 2 study of talabostat in combination with rituximab, a monoclonal antibody, in patients with advanced chronic lymphocytic leukemia (CLL) in ...
Study: green tea might fight leukemia Dec 13, 2005
Webindia123, In the small case study, the researchers report four patients with chronic lymphocytic leukemia appeared to have an improvement in the clinical state of their ...
(PRN) - Telekom Austria Selects Axiom Systems to Deploy Triple ... Dec 13, 2005
Bolsamania.com, New Study Reinforces Increased Life Expectancy with MabCampath(R) (alemtuzumab) for Patients with Advanced, Pretreated B-cell Chronic Lymphocytic Leukemia ... ...
Phase 1 Clinical Data Demonstrates Gemin X Compound GX15-070 is ... Dec 12, 2005
CCNMatthews (press release), ...announced today that results from a Phase 1/2 clinical trial of GX15-070 (obatoclax) in patients with chronic lymphocytic leukemia (CLL) showed GX15-070 was ...
Seattle Genetics Reports Preclinical Data on its SGN-40 and SGN-70 ... Dec 13, 2005
Business Wire (press release), Preclinical studies of SGN-40 demonstrated broad application in B-cell malignancies, including Hodgkin's disease and chronic lymphocytic leukemia, and in ...
Pharmacyclics Announces Presentation and Publication of ... Dec 12, 2005
PR Newswire (press release), ...published Phase 2 study reported that Xcytrin demonstrated single-agent activity in refractory low grade lymphoma (LG) and chronic lymphocytic leukemia (CLL). ...
(PRN) - Newest Rhino Linings Promotion Brings Consumers the Best ... Dec 12, 2005
Bolsamania.com, ...(PRN) - REVLIMID(R) Clinical Results as Oral Treatment Regimen in Chronic Lymphocytic Leukemia Presented at the 47th American Society of Hematology Meeting ... ...
Health and Science News Roundup Dec 13, 2005
Monsters and Critics.com, In the small case study, the researchers report four patients with chronic lymphocytic leukemia appeared to have an improvement in the clinical state of their ...
Genta study sees Genasense combo benefit Dec 12, 2005
BusinessWeek The trial enrolled 241 patients with chronic lymphocytic leukemia. The company did not release specific data. Genta said it expects ...
Vion Presents Cloretazine(R) Data at ASH Annual Meeting Dec 12, 2005
PR Newswire (press release), ...myeloid leukemia and high-risk myelodysplastic syndrome, adult and pediatric brain tumors, small cell lung cancer and chronic lymphocytic leukemia, and in ...
Results from Preclinical Studies of Gemin X's GX15-070 Presented ... Dec 12, 2005
CCNMatthews (press release), Gemin X also presented results from a Phase 1/2 clinical trial of GX15-070 in patients with chronic lymphocytic leukemia (CLL) during the conference. ...
Scientific Advances on Three Lead Cephalon Oncology Compounds to ... Dec 8, 2005
PR Newswire (press release), Bendamustine has been available in Germany for more than three decades for several indications, including NHL, chronic lymphocytic leukemia, multiple myeloma ...
Once a rising star, Xcyte hits end of line Dec 15, 2005
Seattle Post Intelligencer ...hit the wall earlier this year after the Food and Drug Administration questioned the design of the company's clinical trial for chronic lymphocytic leukemia. ...
REVLIMID(R) Clinical Results as Oral Treatment Regimen in ... Dec 13, 2005
PR Newswire (press release), ...for a broad range of hematology and oncology conditions, including; multiple myeloma, myelodysplastic syndromes (MDS), chronic lymphocytic leukemia as well as ...
Pilot Clinical Study of Genasense(R) Plus Rituxan(R) and ... Dec 12, 2005
PR Newswire (press release), R) (oblimersen sodium) Injection, in combination with fludarabine plus rituximab (Rituxan(R); Genentech/IDEC) in patients with chronic lymphocytic leukemia (CLL ...
ASH: Experimental Chemotherapy Drug Effective Against Resistant ... Dec 14, 2005
MedPage Today, It has been used in clinical trials in Europe to treat relapsed or refractory NHL, chronic lymphocytic leukemia, multiple myeloma, and breast cancer. ...
GlycoGenesys, Inc. GCS-100 Cancer Drug Candidate Subject of ... Dec 15, 2005
Genetic Engineering News, ...that is currently in clinical development for treatment of multiple myeloma, solid tumors and a clinical trial for chronic lymphocytic leukemia is planned to ...
HuMax-CD20 Induces Rapid Responses in Relapsed CLL Patients Dec 12, 2005
PR Newswire (press release), FirstCall/ -- Genmab A/S (CSE: GEN) announced today that HuMax(R)-CD20 induces rapid responses in patients with relapsed chronic lymphocytic leukemia (CLL) in ...
TESTICULAR CANCER MOSTLY A YOUNG MAN'S CANCER Nov 22, 2005
Charlotte Sun-Herald, DONOHUE: I have recently been diagnosed with chronic lymphocytic leukemia. ... Chronic lymphocytic leukemia -- CLL -- is the most common kind of adult leukemia. ...
Firm tests therapy on leukemia Nov 30, 2005
Seattle Times, Seattle Genetics said Tuesday it has initiated a 60-patient clinical trial of an experimental cancer therapy for chronic lymphocytic leukemia (CLL). ...
Nipent®/Cytoxan®/Rituxan® Shows High Activity in High-Risk ... Nov 23, 2005
Cancer Consultants (press release), Cytoxan (cyclophosphamide) and Rituxan (rituximab) demonstrates high activity in previously untreated patients with chronic lymphocytic leukemia (CLL) with high ...
HuMax-CD20 Induces Rapid Responses in Relapsed CLL Patients Dec 12, 2005
Yahoo! News (press release) Genmab A/S (CSE: GEN - News) announced today that HuMax®-CD20 induces rapid responses in patients with relapsed chronic lymphocytic leukemia (CLL) in the ...
HealthWrap: Cocaine link to Parkinson's? Dec 13, 2005
Science Daily (press release) And a case study by Mayo Clinic scientists suggests a compound in green tea can help patients with chronic lymphocytic leukemia. ...
CuraGen and TopoTarget Announce Presentation of PXD101 Phase I ... Dec 12, 2005
PharmaLive.com (press release), ...and has demonstrated potential anti-tumor activity against multiple myeloma, non-Hodgkin's lymphoma (NHL) and transformed chronic lymphocytic leukemia (CLL). ...
Treatment with Subcutaneous (SC) MabCampath(R) (alemtuzumab) is ... Dec 12, 2005
PR Newswire UK (press release), ...well-tolerated when compared to historical series of patients receiving intravenous (IV) therapy for fludarabine-refractory chronic lymphocytic leukemia (CLL). ...
Geron Announces Data on the Effects of Its Cancer Drug, GRN163L ... Dec 12, 2005
PharmaLive.com (press release), ...patient cells. GRN163L is currently in a Phase 1-2 clinical trial in patients with chronic lymphocytic leukemia (CLL). The multiple ...
ZymoGenetics Highlights Development Programs at Analyst & Investor ... Dec 8, 2005
PR Newswire (press release), ...with SLE, rheumatoid arthritis and advanced B-cell malignancies, such as multiple myeloma, B-cell non-Hodgkin's lymphoma and chronic lymphocytic leukemia. ...
Advanced multiple myeloma: Revlimid improves overall survival and ... Dec 12, 2005
Xagena.it, ...for a broad range of hematology and oncology conditions, including; multiple myeloma, myelodysplastic syndromes ( MDS ), chronic lymphocytic leukemia as well ...
Seattle Genetics Reports SGN-40 Clinical Data at the American ... Dec 12, 2005
Genetic Engineering News, ...antigen, which is expressed on most B-cell lineage hematologic malignancies, including multiple myeloma, non-Hodgkin's lymphoma and chronic lymphocytic leukemia ...
(PRN) - MathStar Announces New Management Team and Addition of ... Dec 9, 2005
Bolsamania.com, ...[+]. (PRN) - Studies of Nipent(R) in Combination Cancer Therapies for Treatment of Chronic Lymphocytic Leukemia and Graft-versus Host Disease (GVHD) Presented ...
Ascenta AT-101 Data Presented at the American Society of ... Dec 12, 2005
PharmaLive.com (press release), ...that AT-101 binds to proteins Bcl-2, Bcl-XL, Mcl-1 and other proteins in the Bcl-2 family, and induces apoptosis in chronic lymphocytic leukemia (CLL) cells in ...
Cougar Biotechnology Announces Positive Interim Results from Phase ... Dec 12, 2005
PharmaLive.com (press release), ...is an open label dose escalating study where cohorts of subjects with relapsed/refractory non-Hodgkin's lymphoma (NHL) or chronic lymphocytic leukemia (CLL/SLL ...
Pharmacyclics Announces Presentation and Published Abstracts on ... Dec 6, 2005
PR Newswire (press release), Gadolinium (MGd) Has Clinical Activity in Relapsed/Refractory Low Grade Lymphomas (LG) and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Abstract ...
MaxCyte to Be Featured at the SEBIO Investor Forum 2005 Nov 22, 2005
PR Newswire (press release), MaxCyte's pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leukemia (CLL) and several preclinical ...
Man sentenced for shooting incident Nov 21, 2005
Pittsburgh Tribune-Review, UPMC Cancer Centers will sponsor "A Reason To Hope: New Advances in the Treatment of Chronic Lymphocytic Leukemia," from 6 to 7:30 pm Nov. 30 at the Upper St. ...
Health Happenings Nov 20, 2005
Pittsburgh Tribune-Review, 4204. UPMC Cancer Center will sponsor "A Reason to Hope: New Advances in the Treatment of Chronic Lymphocytic Leukemia," 6-7:30 pm Nov. ...
CuraGen deal produces new cancer drug data Dec 13, 2005
DrugResearcher.com, ...demonstrating potential anti-tumour activity against multiple myeloma, non-Hodgkin's lymphoma (NHL) and transformed chronic lymphocytic leukemia (CLL). ...
Chronic leukemias: different forms, different problems, different ... Nov 18, 2005
Pharmaceutical Business Review 18 Nov 2005, 16:11 GMT - Treatment of chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) presents unique problems. ...
BioCryst Out-Licenses BCX-4208 To Roche In Potential $560M Deal Nov 30, 2005
BioWorld Online (subscription), ...cell lymphoma. Its clinical development program also includes studies for chronic lymphocytic leukemia and B-cell leukemia. Beyond ...
DATAMONITOR: Chronic Leukemias: Different forms, different ... Nov 18, 2005
Webbolt Business News (subscription), SUMMARY: Treatment for two forms of leukemia, chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) both present unique problems. ...
US FDA issues warning on Schering's MS drug Campath Dec 1, 2005
Forbes Campath is so far not approved to treat MS. It is only approved for treating a form of blood cancer called B-cell chronic lymphocytic leukemia (B-CLL). ...
Seattle Genetics targets third disease with SGN-40 Nov 29, 2005
Puget Sound Business Journal, The Bothell-based company (NASDAQ: SGEN) has initiated early clinical trials of the drug candidate in patients with chronic lymphocytic leukemia, according to ...
Compiled by Maria Carpico, Pittsburgh Post-Gazette Nov 22, 2005
Pittsburgh Post Gazette, The UPMC Cancer Centers present "A Reason to Hope: New Advances in the Treatment of Chronic Lymphocytic Leukemia," from 6 to 7:30 pm, Nov. ...
Business briefly Nov 30, 2005
Everett Herald, Seattle Genetics Inc. has begun an early human trial to test SGN-40 on patients with chronic lymphocytic leukemia, the most prevalent form of the disease. ...
ΞΕÎ?Η ΔΗΜΟΣΙΕΥΣΗ-ΑÎ?ΑΚΟΙÎ?ΩΣΗ ΤΥΠΟΥ- PRN ... Nov 23, 2005
Athens News Agency, ...that Baxter's new IVIG be indicated for replacement therapy in primary immunodeficiency disorders, myeloma or Chronic Lymphocytic Leukemia (CLL) with severe ...
Superintendent Caston to retire from Escondido job Nov 30, 2005
San Diego Union Tribune, Caston, who was diagnosed with chronic lymphocytic leukemia in October of 2003 and completed chemotherapy in April 2004, said his health was excellent, but he ...
Reduced-Intensity Conditioning Transplant Effective in Aggressive ... Nov 22, 2005
Cancerpage.com, ...report encouraging results for reduced-intensity conditioning allogeneic transplant in patients with poor-prognosis chronic lymphocytic leukemia (CLL). ...
North Shore-LIJ Unveils Plans for $45M Research Facility with ... Nov 18, 2005
Yahoo! News (press release) ...devoted to clinical research, where the institute's Alzheimer's disease, Parkinson's disease, rheumatoid arthritis, chronic lymphocytic leukemia and numerous ...
Saying goodbye to Pastor Bill Nov 19, 2005
Arizona Daily Sun, William John Berg Jr., pastor of Flagstaff's homegrown Shiloh Community Church, died Tuesday night, after a long battle with chronic lymphocytic leukemia. ...
Genta Receives Special Protocol Assessment from FDA for Randomized ... 09 Oct 2006
...that the Company's proposal for a randomized trial of Genasense(R) (oblimersen sodium) Injection in patients with chronic lymphocytic leukemia (CLL) has ... Drug Newswire (press release),
Xanthus Pharmaceuticals Expands Oncology Pipeline with Late-Stage ... 09 Oct 2006
...by Schering AG in the European Union and Canada under the trade name, Fludara(R), for the treatment of relapsed B-cell chronic lymphocytic leukemia (CLL). ... Drug Newswire (press release),
Palatal Enlargement in Chronic Lymphocytic Leukemia Sep 13, 2006
SUMMARY: Palatal involvement in chronic lymphocytic leukemia (CLL) is rare and has only been reported 3 previous times in the non-radiology literature. ... AJNR (subscription),
Market Report -- In Play (GNTA) Oct 6, 2006
Genta receives special protocol assessment from FDA for randomized trial of Genasense plus chemotherapy in chronic lymphocytic leukemia Co announces its ... MSN Money
Genta Completes New Trial Design Oct 6, 2006
Genta first submitted the SPA in December. Genta hopes to get approval for Genasense for use with other therapies to treat chronic lymphocytic leukemia. ... MSN Money
Genta Gets Drug Trial Boost Oct 6, 2006
Administration completed a special protocol assessment of the proposed trial, which will enroll patients with symptomatic chronic lymphocytic leukemia who have ... TheStreet.com
Genta Receives SPA from FDA for Trial of Genasense in Leukemia Oct 6, 2006
Genta Incorporated (Nasdaq: GNTA) said its proposal for a randomized trial of Genasense Injection in patients with chronic lymphocytic leukemia has completed ... StreetInsider.com (subscription),
UPDATE 1-Genta, FDA agree on Genasense trial design; shares rise Oct 6, 2006
Genta said its proposal for a randomized trial of Genasense injection in patients with chronic lymphocytic leukemia (CLL) completed Special Protocol Assessment ... Reuters
FDA OK's trial of Genta's Genasense Oct 6, 2006
BERKELEY HEIGHTS, NJ, Oct. 6 (UPI) -- Genta said Friday the US Food and Drug Administration approved its trial of Genasense for chronic lymphocytic leukemia. ... United Press International
FDA OK's Trial of Genta's Genasense Oct 6, 2006
Genta said Friday the US Food and Drug Administration approved its trial of Genasense for chronic lymphocytic leukemia. However, Genta ... International News Service,
Pharma Sector: Few Newsmakers Of The Week - Abbott ... Oct 6, 2006
Special Protocol Assessment or SPA from the FDA for randomized trial of Genasense in combination with chemotherapy in patients with chronic lymphocytic leukemia ... Trading Markets,
MaxCyte to Present at the 2006 BIO InvestorForum 2006 Oct 6, 2006
...as well as in development collaborations with leading researchers: one in Phase I/II clinical trials for treatment of chronic lymphocytic leukemia (CLL) and ... PharmaLive.com (press release),
Narrative Review: Initial Management of Newly Diagnosed, Early ... Sep 18, 2006
Chronic lymphocytic leukemia is one of the most common malignant lymphoid diseases in the western world and is frequently diagnosed by internists. ... Annals of Internal Medicine
Stem-cell transplant helped Laura Cross beat leukemia Sep 23, 2006
...transplant. The transplant, she knew, was her best shot at sending her chronic lymphocytic leukemia into a long remission. Cancer ... TheDenverChannel.com,
Xanthus In-Licenses US Rights To Oral Fludarabine Oct 4, 2006
...deal for everybody.? The chemotherapy Fludarabine is a standard of care for chronic lymphocytic leukemia (CLL). The intravenous ... Therapeutics Daily (subscription) (press release),
Researchers' work from Canada, the People's Republic of China and ... Oct 5, 2006
...study from Canada has reported that the TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells. ... Therapeutics Daily (subscription) (press release),
Xanthus gains rights to oral cancer drug Oct 4, 2006
...is currently marketed by Schering AG in the EU and Canada under the trade name, Fludara, for the treatment of relapsed B-cell chronic lymphocytic leukemia (CLL ... Pharmaceutical Business Review
Leukemia survivor trains for next challenge Sep 18, 2006
...each year. Perez has chronic lymphocytic leukemia and is worried that it might, one day, affect her children and grandchildren. She ... Montgomery Advertiser,
Millennium Makes $515M Offer For AnorMED, Tops Genzyme Sep 26, 2006
...patients with certain hematological diseases more responsive to chemotherapy, including those with acute myelogenous leukemia and chronic lymphocytic leukemia. ... BioWorld Online,
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology ... Sep 26, 2006
...certain hematological diseases more responsive to chemotherapy, including patients with acute myelogenous leukemia (AML) and chronic lymphocytic leukemia (CLL ... Yahoo! News (press release)
Awaiting Genasense Decision, Genta Gets $16M In Stock Sale Sep 20, 2006
By Jennifer Boggs. With an FDA decision expected by the end of next month on the antisense drug Genasense in chronic lymphocytic leukemia, Genta Inc. ... BioWorld Online,
Gemin X Biotechnologies Initiates Phase 2 Clinical Trial Program ... Sep 15, 2006
A Phase 1b study in 25 patients with chronic lymphocytic leukemia (CLL) demonstrated that GX15-070 administered at doses of 3.5 to 40 mg/m2 as a one to three ... PipelineReview.com (press release),
ICAAC: Got Clostridium Difficile Diarrhea? Got Milk? Sep 29, 2006
On the other hand, he reported the case of an 82-year-old man with chronic lymphocytic leukemia, who was on immunosuppressive medication and had suffered a ... MedPage Today,
Goldman Sachs Lifts Genmab Target Sep 21, 2006
Lifts 09 revenue and profit forecasts, based on the launch of HuMax-CD20 for Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. Keeps at buy. ... newratings.com
Residents take advantage of health screenings Sep 27, 2006
79, of Bloomfield, also wanted to find out her risk for heart attack or stroke because she suffers from chronic lymphocytic leukemia — results from an ... Farmington Daily Times,
Flu clinics set this month for vets who are enrolled Oct 1, 2006
...to be associated with Agent Orange: chloracne, Type II diabetes, Hodgkin’s disease, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, multiple myeloma ... Providence Journal,
Friends delivering help to ailing postal worker Sep 28, 2006
..."I just can't believe how big it got, and how much people are doing.". Droppa was diagnosed with chronic lymphocytic leukemia (CLL) five years ago. ... East Brunswick Sentinel,
Genta Announces Closing of Common Stock Offering Sep 25, 2006
...for the use of Genasense plus fludarabine and cyclophosphamide for treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL). ... Yahoo! News (press release)
Pharma Sector: Few Newsmakers Of The Week - Bristol Myers, Mylan ... Sep 16, 2006
Campath, which is not approved to treat multiple sclerosis, is only approved for treating a form of blood cancer called B-cell chronic lymphocytic leukemia. ... Trading Markets,
Genzyme Releases Interim Campath-MS Data Sep 14, 2006
...competitor's drug in treating multiple sclerosis. Campath is approved to treat B-cell chronic lymphocytic leukemia. The company had to halt ... Houston Chronicle,
Genzyme releases interim Campath-MS data Sep 14, 2006
...drug in treating multiple sclerosis. Campath is approved to treat B-cell chronic lymphocytic leukemia. The results from the clinical ... Eyewitness News,
Panel Sneezes, Genta Catches Cold Sep 11, 2006
The trial therapy, called Genasense, is an injectable drug for treating relapsed or treatment-resistant chronic lymphocytic leukemia, one of four major types ... Business New Jersey (subscription),
A survivor's quest Sep 12, 2006
Maureen describes her mother as a graceful, dignified woman who battled chronic lymphocytic leukemia the last 12 years of her life. ... Cincinnati Enquirer,
TODAY's Chat: Marty Liquori, Part 2 Sep 18, 2006
...national spokesperson for the Leukemia and Lymphoma Society's Team in Training, and six months later you were diagnosed with chronic lymphocytic leukemia (CLL ... Runner's World
Genzyme Reports Interim Results from Trial of Campath(R) for ... Sep 14, 2006
About Campath Campath (alemtuzumab), is indicated in the United States for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) in patients who have ... PR Newswire (press release),
UPDATE 1-Genzyme MS drug shows benefit vs Serono's in trial Sep 14, 2006
...nearly 3 percent. Campath is currently approved to treat B-cell chronic lymphocytic leukemia, a rare blood cancer. It is marketed ... Reuters
Genta Shares Up Sep 18, 2006
Administration panel recommended against approving Genasense to treat the most common adult form of the blood cancer refractory chronic lymphocytic leukemia. ... Houston Chronicle,
Campath showing potential to treat multiple sclerosis Sep 14, 2006
Campath is currently approved by the Food and Drug Administration to treat B-cell chronic lymphocytic leukemia, a rare form of blood cancer. ... Bizjournals.com,
Multiple sclerosis: Campath more effective than Rebif Sep 17, 2006
Campath ( Alemtuzumab ), is indicated in the United States for the treatment of B-cell chronic lymphocytic leukemia ( B-CLL ) in patients who have been treated ... Xagena.it,
Trader’s Radar: Genta, Generex, Applied Materials, Toll Brothers Sep 18, 2006
41% after an advisory panel of the Food and Drug Administration failed to recommend the drug to be approved for the treatment of chronic lymphocytic leukemia. ... Ant & Sons
REVLIMID(R) Marketing Authorization Application Accepted by EMEA ... Oct 26, 2005
PR Newswire (press release), ...conditions, including; multiple myeloma, the malignant blood cell disorders known as myelodysplastic syndromes (MDS), chronic lymphocytic leukemia as well as ...
(PRN) - Business in Asia -- Oct. 21, 2005 ... [+] Oct 21, 2005
Bolsamania.com, Published in Journal of Clinical Oncology Show FluCam Regimen to Be Highly Effective in Treating Relapsed and Refractory B-Cell Chronic Lymphocytic Leukemia ...
Seattle Genetics Reports Third Quarter 2005 Financial Results Oct 25, 2005
PharmaLive.com (press release), ...remainder of 2005, including initiation of a SGN-33 clinical trial, expansion of SGN-40 into a phase I/II trial in chronic lymphocytic leukemia and multiple ...
Health notes Oct 19, 2005
Blue Springs Examiner, A free telephone education workshop for people living with chronic lymphocytic leukemia, their families, friends and medical professionals is being held from 12 ...
BioCryst to Present at the Bear Stearns 18th Annual Healthcare ... Sep 7, 2005
...being studied in a Phase I trial with an oral formulation in cutaneous T-cell lymphoma (CTCL) and a Phase II trial in chronic lymphocytic leukemia (CLL). ... Yahoo! News (press release)
BioCryst Initiates Fodosine(TM) Oral Phase II Clinical Trial in ... Aug 31, 2005
The trial is designed to evaluate the efficacy and safety of Fodosine(TM) in patients with advanced, fludarabine-refractory chronic lymphocytic leukemia (CLL). ... PR Newswire (press release),
Hi. My name is Tommy, and I have leukemia Aug 16, 2005
I figured because Orman is an oncologist he was going to tell me I had cancer. "It's a type of leukemia, chronic lymphocytic leukemia," he said, "CLL.". ... Venice Gondolier,
Vion to Present at Bear Stearns Healthcare Conference Sep 8, 2005
Trials of Cloretazine(R) as a single agent in adult and pediatric brain tumors and chronic lymphocytic leukemia, and in combination with temozolomide in ... PR Newswire (press release),
Geron says study shows cancer drug success Sep 6, 2005
...control mice. The drug is currently in clinical testing in a Phase I/II trial in patients with chronic lymphocytic leukemia. In ... San Jose Business Journal,
The San Francisco 49ers and Novacea Join Forces to Tackle Prostate ... Sep 6, 2005
...or AQ4N, is in a Phase 1 study in advanced malignancies and a Phase 1/2 study in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia. ... PR Newswire (press release),
Radio Beat: 'Do-it-yourself' radio programs are well-oiled by ... Sep 7, 2005
Patient education is a subject Schorr has more than a passing interest in, having been diagnosed in 1996 with chronic lymphocytic leukemia; he's now in ... Seattle Post Intelligencer
Genmab to Present Interim Results in Phase I/II HuMax(R)-CD20 CLL ... Aug 22, 2005
Data to be Presented at 11th International Workshop on Chronic Lymphocytic Leukemia COPENHAGEN, Denmark, Aug. 22 /PRNewswire-FirstCall ... PR Newswire (press release),
Genmab to Present Interim Results in Phase I/II HuMax(R)-CD20 CLL ... Aug 22, 2005
Genmab A/S (CSE: GEN) announced today that interim results in the HuMax-CD20 Phase I/II study to treat chronic lymphocytic leukemia (CLL) will be presented at ... PR Newswire UK (press release),
Geron Announces Publications Demonstrating Efficacy of GRN163L ... Sep 6, 2005
GRN163L is currently in clinical testing in a Phase I/II trial in patients with chronic lymphocytic leukemia (CLL). Additional trials are being planned. ... PharmaLive.com (press release),
New Molecule Stops Cancer's Spread Sep 2, 2005
June. It will be conducted at two medical centers in New York, which are recruiting patients with chronic lymphocytic leukemia. ... Forbes
Sanofi-aventis Announces Strong Growth In 2005 Aug 30, 2005
Alvocidib in refractory Chronic Lymphocytic Leukemia (CLL): In a study of 23 patients with CLL who failed fludarabine treatment, Alvocidib activity was ... PR Newswire (press release),
Cancer series struck a chord with numerous readers Aug 23, 2005
Yes, he does, and he is damn good at it. I was diagnosed with chronic lymphocytic leukemia a little more than two years ago. CLL ... Venice Gondolier,
Biogen Idec and Genentech Submit a Supplemental Biologics License ... Aug 31, 2005
...have been described as paraneoplastic pemphigus and are known to be associated with various B-cell lymphomas, particularly NHL and chronic lymphocytic leukemia ... Yahoo! News (press release)
BioCryst starts phase I pharmacokinetic study of Fodosine Aug 9, 2005
...has been designated an orphan drug for several indications, including T-cell leukemia, cutaneous T-cell lymphoma (CTCL), chronic lymphocytic leukemia (CLL) and ... Pharmaceutical Business Review
Sanofi-aventis Announces Strong Growth In 2005 Aug 30, 2005
Eight products are entering the development pipeline, including Alvocidib which is moving directly into phase III trials in Chronic Lymphocytic Leukemia. ... Yahoo! News (press release)
GlycoGenesys, Inc. Comments on 2005 Second Quarter Financial ... Aug 19, 2005
...tumors and Phase I/II trial in multiple myeloma, as well as with the preparations for initiating the planned trial for chronic lymphocytic leukemia," stated Mr ... Business Wire (press release),
Cancer diagnosis: No self-pity, no anger Aug 18, 2005
After telling me I had chronic lymphocytic leukemia, or CLL, Dr. Stephen Orman knew I was scared. But he sounded like he had enough confidence for both of us. ... Venice Gondolier,
The story Aug 20, 2005
In the beginning, the last thing on my mind after being diagnosed with chronic lymphocytic leukemia was going public. First rule ... Venice Gondolier,
FDA Sends SuperGen Warning Letter Over Nipent Handout Aug 22, 2005
In a clinical investigation in patients with refractory chronic lymphocytic leukemia using Nipent at the recommended dose in combination with fludarabine ... PharmaLive.com (press release),
Genmab, Serono Sign Potential $215M Deal For HuMax-CD4 Aug 18, 2005
...in rheumatoid arthritis. That product recently completed a Phase I study in B-cell chronic lymphocytic leukemia. Another product ... BioWorld Online (subscription),
Pharmacyclics Reports Fourth Quarter and Fiscal 2005 Financial ... Aug 18, 2005
1 and 2 clinical trials showing that Xcytrin has independent anti-tumor activity as a single agent in advanced recurrent chronic lymphocytic leukemia (CLL), non ... Yahoo News (press release)
Genmab Initiates HuMax(R)-CD20 Phase II Study In Rheumatoid ... Aug 16, 2005
...at http://www.genmab.com. A Phase I/II trial to treat patients with chronic lymphocytic leukemia is ongoing. About CD20 The CD20 ... PR Newswire (press release),
Allogeneic Mini-Transplant Effective for Refractory Chronic ... Jun 30, 2005
...of Clinical Oncology, allogeneic mini-transplants appear to be a highly effective treatment option in patients with refractory chronic lymphocytic leukemia. ... Cancer Consultants (press release),
Hope for patients with Chronic lymphocytic leukemia Jun 29, 2005
...the first time in India ,German Remedies, a part of the Zydus group, has launched Fludara Oral (fludarabine) for the treatment of chronic lymphocytic leukemia. ... MedIndia,
Transplantation May Prolong Chronic Lymphocytic Leukemia Survival Jun 28, 2005
...transplantation (HCT) after nonmyeloablative conditioning can prolong survival for some patients with advanced chronic lymphocytic leukemia (CLL), according to ... Cancerpage.com,
Chronic lymphocytic leukemia tampers with T cells Jun 16, 2005
Queen Mary University of London, compare the global gene expression patterns of T cells from patients with untreated B cell chronic lymphocytic leukemia (B-CLL ... Medical News Today,
Eradication of Minimal Residual Disease in B-Cell Chronic ... Jun 14, 2005
The Journal of Clinical Oncology has recently published a study reporting that remission may be accomplished among chronic lymphocytic leukemia patients with ... Cancer Consultants (press release),
Regimen Consisting of Fludara®, Cytoxan® and Rituxan® Highly ... Jun 23, 2005
...cyclophosphamide) plus the targeted agent Rituxan (rituximab) provides promising anticancer responses in patients with chronic lymphocytic leukemia (CLL) that ... Cancer Consultants (press release),
FDA Approves New Fill/Finish Facility for ONTAK(R); Includes ... Jul 5, 2005
Recent and current ONTAK development programs include Phase II clinical trials in patients with chronic lymphocytic leukemia, peripheral T-cell lymphoma, B ... Business Wire (press release),
Educator Downshifts for Latest Challenge Jul 5, 2005
She's been thinking a lot about her legacy lately; on her 59th birthday this year, a doctor told her she has chronic lymphocytic leukemia. ... Washington Post,
Fludara®, Cyclophosphamide and Rituxan® Active in Early and Late ... Jun 24, 2005
...and Rituxan (rituximab) produces results superior to any previously tested for treatment of relapsed and refractory chronic lymphocytic leukemia (CLL).[1] They ... Cancer Consultants (press release),
Struggling Xcyte replaces chief exec Jul 6, 2005
It is focusing on its Xcellerated T Cells therapy program, which enhances the body's immune system, and its application to chronic lymphocytic leukemia. ... Seattle Post Intelligencer,
Active community leader Jul 2, 2005
Carl Hemp, of Ravenna Township, who also served on the Cottage Grove Planning Commission, died June 21 of complications of chronic lymphocytic leukemia at St. ... Pioneer Press,
Point Therapeutics Announces Annual Meeting of Stockholders on ... Jul 5, 2005
...melanoma, talabostat in combination with cisplatin in metastatic melanoma, and talabostat in combination with rituximab in advanced chronic lymphocytic leukemia ... dBusinessNews Boston (press release),
Genta Initiates New Drug Application for Genasense(R) in Patients ... Jun 30, 2005
...for the use of Genasense in combination with fludarabine plus cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia (CLL) who have ... Yahoo News (press release)
BioCryst Receives FDA Fast Track Status for Fodosine(TM) in the ... Jun 20, 2005
BioCryst also plans to initiate a Phase I/II trial in B-cell acute lymphoblastic leukemia and a Phase II trial in chronic lymphocytic leukemia (CLL) during 2005 ... mysan.de (Pressemitteilung),
Biotech, pharma follow broader markets south Jun 30, 2005
Genasense. Genta is seeking to have the drug approved for chronic lymphocytic leukemia in the US and for advanced melanoma in Europe. ... Investor's Business Daily (subscription)
Small Cancer Risk from Low-Dose Radiation Jun 28, 2005
...increased risk of death from all cancers, excluding leukemia, and a 19 percent increased risk of death from leukemia, excluding chronic lymphocytic leukemia. ... Forbes
Cadila launches leukemia drug Jun 9, 2005
Ltd said, on Thursday, German Remedies, a part of the Zeus Group, has launched Flooder Oral (Fludarabine) for the treatment of Chronic Lymphocytic Leukemia. ... Sify,
Study: Low-radiation radiation causes cancer Jun 29, 2005
...millisielverts (mSV) would increase all kinds of cancer risk by 10 percent and the death rate of leukemia by 19 percent, excluding chronic lymphocytic leukemia ... Food Consumer,
Genasense(R) plus Rituximab Reported Active in Patients with ... Jun 13, 2005
4). Ongoing work is also assessing the use of Genasense in combination with rituximab plus fludarabine in patients with chronic lymphocytic leukemia (CLL). ... PR Newswire (press release)
Hope Greets New Millennium CEO Jun 29, 2005
Positive results of Revlimid trials in chronic lymphocytic leukemia were presented at the American Society of Clinical Oncology meeting last month. ... TheStreet.com
REVLIMID(R) (lenalidomide) Study in Low and Intermediate-1 Risk ... Jun 6, 2005
...of the EHA, REVLIMID clinical findings were presented in previously treated multiple myeloma, relapsed or refractory chronic lymphocytic leukemia, as well as ... Yahoo News (press release)
Biologist Works to Understand Autoimmune Disease Jun 28, 2005
It is a personal mission for Centola. His father died of autoimmune Hemolytic anemia, which was associated with chronic lymphocytic leukemia. ... RedNova.com,
Cancer survivor trains for big event Jun 16, 2005
The director of operations for North Thurston Public Schools, Perkins learned in 1999 that he had chronic lymphocytic leukemia. ... The Olympian,
Preliminary Phase IIb Study Showed Rituxan Improved Symptoms in ... Jun 9, 2005
...have been described as paraneoplastic pemphigus and are known to be associated with various B cell lymphomas, particularly NHL and chronic lymphocytic leukemia ... Yahoo News (press release)
Ottawa pressured to disclose Agent Orange facts Jun 13, 2005
...there is believed to be an association, especially in relation to such cancers as soft tissue sarcoma, Hodgkin's disease and chronic lymphocytic leukemia. ... CTV,
Clarient Launches New Internet-Based PATHSiTE(TM) Flow Cytometry ...
...analysis of the submitted specimen or a more restricted analysis for specific disease states such as multiple myeloma or chronic lymphocytic leukemia. ... PR Newswire (press release)
Chronic Lymphocytic Leukemia - CLL - Patients Reach Five-Year ... May 25, 2005
Chronic Lymphocytic Leukemia (CLL) is the most prevalent form of adult leukemia. According to a recent study, 84 percent of patients ... Genetic Engineering News,
REVLIMID(R)(Lenalidomide) Study in Chronic Lymphocytic Leukemia ... May 15, 2005
FirstCall/ -- Celgene Corporation (Nasdaq: CELG - News) announced that clinical data from a REVLIMID study in Chronic Lymphocytic Leukemia (CLL) were presented ... Yahoo News (press release)
REVLIMID(R)(Lenalidomide) Study in Chronic Lymphocytic Leukemia ... May 15, 2005
15 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) announced that clinical data from a REVLIMID study in Chronic Lymphocytic Leukemia (CLL) were ... PR Newswire (press release)
REVLIMID(R) (lenalidomide) New Drug Application Accepted for ... Jun 7, 2005
...oncology conditions, including; multiple myeloma, the malignant blood cell disorders known as myelodysplastic syndromes, chronic lymphocytic leukemia, as well ... Yahoo News (press release)
FDA Gives Clearance to GRN163L for Treatment of Chronic ... May 23, 2005
US Food and Drug Administration (FDA) to initiate clinical testing of its lead anti-cancer compound, GRN163L, in patients with chronic lymphocytic leukemia (CLL ... RxPG NEWS,
Chronic lymphocytic leucemia, MRD-negative remission with ... May 8, 2005
The 84 percent of patients who had no detectable traces of chronic lymphocytic leukemia ( CLL ) after receiving Alemtuzumab had survived for at least 5 years. ... Xagena.it,
Museum chief rebukes newspaper May 24, 2005
Stafford said in a letter to board members that his 10-day trip to Bonaire helped his "battle with chronic lymphocytic leukemia.". ... Milwaukee Journal Sentinel,
Family's fund-raiser is many cuts above the rest Jun 6, 2005
Eight members of Christina Caputo's family - including her father and late grandfather - have been stricken with chronic lymphocytic leukemia. ... Boston Herald,
Geron gets FDA OK to test leukemia drug May 23, 2005
The study will be conducted in patients with chronic lymphocytic leukemia, a disease where a single cancerous cell in the bone marrow can result in the ... BusinessWeek
Eradication of Residual Disease Prolongs Chronic Leukemia Survival May 26, 2005
NEW YORK MAY 26, 2005 (Reuters Health) - Patients with B-cell chronic lymphocytic leukemia (CLL) who have eradication of minimal residual disease with ... Cancerpage.com,
Geron gets OK to test anti-cancer compound May 24, 2005
Menlo Park announced Monday it received FDA clearance to start clinical testing of its lead anti-cancer compound in patients with chronic lymphocytic leukemia. ... San Jose Mercury News,
Radiation Workers at Higher Risk for Developing Myelodysplastic ... May 24, 2005
In the atomic bomb survivors, there was a clear increase in non-chronic lymphocytic leukemia, but only two of 50 persons who developed AML (and for whom ... Am J Roentgenology (subscription)
Geron Announces Publication Characterizing GRN163L, Its Telomerase ... Jun 1, 2005
Geron recently received FDA clearance to begin human clinical studies of GRN163L in patients with chronic lymphocytic leukemia (CLL). ... Business Wire (press release),
HuMax(R)-CD20 Effective in Killing Tumor Cells With Very Low ... Jun 2, 2005
...in three ongoing Phase I/II clinical studies -- two to treat cancer involving B-cells (non-Hodgkin's lymphoma and chronic lymphocytic leukemia) and one to ... Yahoo News (press release)
Biotech Continues Its Steady Improvement in May Jun 1, 2005
...company has obtained FDA clearance to initiate clinical testing of its lead anti-cancer compound, GRN163L, in patients with chronic lymphocytic leukemia (CLL). ... Yahoo News (press release)
Enzyme Stopper Combats Cancers Jun 4, 2005
The Food and Drug Administration this week cleared the drug for testing in people with chronic lymphocytic leukemia, which is diagnosed in roughly 8,200 people ... RedNova.com,
To: National Desk, Health Reporter May 25, 2005
Originally developed for the treatment of B-cell chronic lymphocytic leukemia, Campath is a monoclonal antibody that targets the CD52 antigen expressed on T ... U.S. Newswire (press release),
Highlights of rising and falling US stocks May 23, 2005
Food and Drug Administration clearance to begin clinical testing of its lead anticancer compound, GRN163L, in patients with chronic lymphocytic leukemia. ... Investor's Business Daily (subscription)
Keller hospitalized; murder trial delayed again May 24, 2005
...low. Keller has been battling chronic lymphocytic leukemia for more than a decade and has a history of heart problems. According ... Palm Beach Daily News,
Genta drug boosts chemotherapy effect May 13, 2005
Patients participating in the trial were being treated for relapsed or drug-resistant chronic lymphocytic leukemia, a common form of leukemia in adults. ... BusinessWeek
Updated Analysis from Phase 3 Trial of Genasense(R) in CLL Shows ... May 13, 2005
...of results from the Company's Phase 3 trial of Genasense (oblimersen sodium) Injection in patients with relapsed or refractory chronic lymphocytic leukemia (CLL ... PR Newswire (press release)
BioCryst Pharmaceuticals Appoints Jonathan M. Nugent Vice ... May 10, 2005
Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including cutaneous T-cell lymphoma; chronic lymphocytic leukemia (CLL) and ... Yahoo News (press release)
Benefit supper, auction and bake sale planned for Jerry Flatness 17 Mar 2005
A freewill donation will be received for the supper. Flatness was diagnosed with Chronic Lymphocytic Leukemia and small lymphocytic lymphoma in June 1999. ... Albert Lea Tribune
KineMed Announces Award of SBIR Phase I Grant for Program in ... 17 Mar 2005
...grant is in addition to over $5 million dollars previously awarded in the areas of prostate cancer, osteoarthritis, toxicology, and chronic lymphocytic leukemia ... Yahoo News
GlycoGenesys, Inc. Closes on First of Two Tranches in a $6,500,000 ... 17 Mar 2005
...in multiple myeloma, funding the initiation of its Phase I/II dose ranging clinical trial for GCS-100LE in chronic lymphocytic leukemia, manufacturing drug ... dBusinessNews Boston
BioCryst Pharmaceuticals Successfully Completes Phase I Trial With ... Mar 15, 2005
Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL; chronic lymphocytic leukemia (CLL) and ... PR Newswire
Titan Reports Fourth Quarter and Year End 2004 Results Mar 14, 2005
Following these results, the Company has refocused priorities and Pivanex studies in chronic lymphocytic leukemia and melanoma are being discontinued. ... Yahoo News
Biotech Takes a Hit in February Mar 13, 2005
...the company withdrew its submission to the FDA of the clinical protocol for a planned Phase II/III trial of Xcellerated T Cells in chronic lymphocytic leukemia ... AXcess News
Vietnam's Agent Orange Victims Feel Cheated by US Court Mar 13, 2005
Exposure to Agent Orange can result in chronic lymphocytic leukemia (CLL), the US National Institute of Medicine said in a 2003 report. ... Inter Press Service (subscription)
Point Therapeutics to Present at SG Cowen Health Care Conference Mar 14, 2005
...and in combination with cisplatin in advanced metastatic melanoma, and in combination with rituximab in subjects with advanced chronic lymphocytic leukemia. ... PharmaLive.com
MaxCyte to Be Featured at Windhover Convergence: The Drug/Device ... Mar 10, 2005
MaxCyte's pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leukemia (CLL) and several preclinical ... PR Newswire
KineMed Reports Data Demonstrating New Insights into the Cellular ... Mar 1, 2005
...online issue, of the Journal of Clinical Investigation demonstrating new insights into the natural history and progression of chronic lymphocytic leukemia (CLL ... Yahoo News
Couple clears immigration hurdles, battle cancer Mar 12, 2005
24, 2003, wedding, Leonard was diagnosed with chronic lymphocytic leukemia, possibly caused by exposure to Agent Orange, a defoliant used during the Vietnam War ... Tuscaloosa News (subscription)
Xcyte Therapies, Inc. Announces Publication of Paper Describing ... Feb 15, 2005
...today the publication of a scientific paper describing the mechanism of action of its lead product, Xcellerated T Cells, in chronic lymphocytic leukemia (CLL). ... Business Wire
Cancer Genetics Inc, US comes to India Mar 11, 2005
We also aim to bring competition and innovation to the Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Myloid leukemia, Sarcoma and ... Express Healthcare Management
Recent breakthroughs in common adult leukemia Feb 24, 2005
Journals Correspondent, New England Journal of Medicine (NEJM) recently invited three of the world's foremost experts on chronic lymphocytic leukemia (CLL) to ... RxPG NEWS
Experts denounce continuing effects of Agent Orange in Vietnam Mar 11, 2005
Exposure to Agent Orange can result in chronic lymphocytic leukemia (CLL), the US National Institute of Medicine, which is linked to the National Academy of ... Channel News Asia
Faces of Medicaid: Gary Griffin Mar 13, 2005
...ago, Gary Griffin collapsed while gassing up his taxi cab, landing him in the hospital with an injured shoulder and a diagnosis of chronic lymphocytic leukemia ... Salt Lake Tribune
Industry Insider: Four firms gather laurels for their ... Mar 9, 2005
The company's ambitious pipeline includes prospective treatments for rheumatoid arthritis, head and neck cancer and chronic lymphocytic leukemia. ... Newark Star Ledger
Scientists Disprove Two Tenets Of Common Leukemia Feb 17, 2005
Due to the relatively slow disease progression of chronic lymphocytic leukemia (CLL), doctors thought it was caused by a gradual accumulation of leukemia cells ... Science Daily
Leukemia Cells Surprise Researchers Feb 10, 2005
10 (HealthDay News) -- Scientists have long believed that chronic lymphocytic leukemia (CLL) cells don't die, and they proliferate at a very slow rate. ... HealthCentral.com
The Very Unexpected Life And Death Of A Leukemic Cell Feb 16, 2005
B cell chronic lymphocytic leukemia (CLL) is an incurable disease in which cells in the bone marrow grow and survive to the point where they become abnormal ... Science Daily
Genta Incorporated Announces Fourth Quarter and Year End 2004 ... Feb 17, 2005
The Company has completed three Phase 3 randomized clinical trials of Genasense in malignant melanoma, chronic lymphocytic leukemia and multiple myeloma ... Yahoo News
BioCryst to Raise Approximately $23.9 Million Through Sale of ... Feb 17, 2005
...and Drug Administration for three indications: T-cell non-Hodgkin’s lymphoma, including cutaneous T-cell lymphoma; chronic lymphocytic leukemia (CLL) and ... mysan.de (Pressemitteilung)
Genzyme Delivers Excellent Fourth-Quarter and 2004 Performance ... Feb 17, 2005
Enrollment is complete in a Phase 3 trial for earlier-line use of CAMPATH in B-cell chronic lymphocytic leukemia, and interim data are expected this year. ... Yahoo News
Chronic Lymphocytic Leukemia Archive
Chronic lymphocytic leukemia, or CLL, is a cancer in which too many lymphocytes (a type of white blood cells) are produced.
CLL has two subtypes: T-cell and B-cell. The latter (B-cell) is the most common form (about 95%) and shows up mainly in the bone marrow and blood. B-cell CLL is closely related to (and some may consider it the same as) a disease called Small-cell lymphocytic lymphoma (SLL), a type of non-Hodgkin's lymphoma expressed primarily in the lymph nodes.
CLL is the most-diagnosed form of leukemia in adults. Men are twice as likely to develop CLL as women, however the key risk factor is age: over 75% of new cases are diagnosed in patients over age 50. About 7300 new cases of CLL are diagnosed in the U.S. each year.
|
|
|
